Loading clinical trials...
Loading clinical trials...
REVERSEII: Validation of the "Men and HERDOO2"- A Clinical Decision Rule to Identify Patients With "Unprovoked" Venous Thromboembolism Who Can Discontinue Anticoagulants After 6 Months of Treatment.
Conditions
Interventions
Application of the"Men continue and HER DOO2" rule
Locations
23
United States
UC Davis
Santa Monica, California, United States
Penobscot Bay Medical Center
Rockport, Maine, United States
Duke University
Durham, North Carolina, United States
Prince of Wales Hospital
Sydney, New South Wales, Australia
CUB Hopital Erasme
Brussels, Belgium
CDHA-Queen Elizabeth II Health Science Centre
Halifax, Nova Scotia, Canada
Start Date
November 1, 2008
Primary Completion Date
January 1, 2015
Completion Date
July 1, 2016
Last Updated
September 1, 2016
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions